期刊文献+

四环素诱导Balb/c小鼠肝脏脂肪代谢相关基因表达谱的变化 被引量:2

Effects of Tetracycline on Expression Profiles of Genes A-ssociated with Lipid Metabolism in Balb/c Mouse Liver
下载PDF
导出
摘要 背景与目的利用小鼠毒理基因芯片观察四环素对Balb/c小鼠肝脏脂肪代谢相关基因表达的影响。材料与方法设计200mg/(kg.d)和50mg/(kg.d)剂量条件下包含3个时相点的四环素致小鼠肝脏损伤动物模型,提取小鼠肝脏RNA样本,利用小鼠毒理基因芯片进行杂交实验。结果综合各组基因表达谱分析发现与脂肪代谢相关的差异表达基因28个,涉及肝内脂肪合成、分解代谢、转运等多方面,对这些基因的功能和相互关系进行了初步分析和探讨。结论四环素作用于Balb/c小鼠肝脏后引起脂肪代谢相关多个基因显著改变,为深入探讨四环素肝脏毒性分子机制提供了线索。 BACKGROUND & AIM: To search for the differentially expressed genes related to lipid metabolism in the liver of Balb/c mouse treated by tetracycline hydrochloride using mouse toxicological microarray. MATERIAL AND METHOVS: The mouse toxicological microarray was developed. The model of tetracycline hydrochloride damaging mouse liver ,which included two doses (200 mg/(kg·d) and 50 mg/(kg · d))and three time phases,was established.The total RNA of mouse liver was isolated for hybridization experiment of the microarray. RESULTS: 28 genes differentially expressed in all treated groups were found. These were involved in lipid synthesis,catabolisim and transport in the liver, preliminary analyses of these gene functions and their relationship were performed, CONCLUSION: Multiple genes were markedly changed in the liver of Balb/c mouse treated by tetracycline hydrochloride.This set the stage for further research on the molecular mechanisms of the hepatoxicity of tetracycline.
出处 《癌变.畸变.突变》 CAS CSCD 2006年第2期144-148,共5页 Carcinogenesis,Teratogenesis & Mutagenesis
基金 国家973课题分题(No.2002CB512901) 国家杰出人才基金项目(No.3012503) 国家自然科学基金(No.30200354 No.30271136)
关键词 基因芯片 四环素 肝脏 gene chip tetracycline liver
  • 相关文献

参考文献11

  • 1敖琳,曾志雄,方志俊,胡冉,高利宏,杨梦苏,曹佳.小鼠毒理基因芯片的设计和制作[J].癌变.畸变.突变,2006,18(2):135-138. 被引量:8
  • 2敖琳,高利宏,胡冉,曾志雄,方志俊,曹佳,杨梦苏.小鼠毒理基因芯片的可靠性验证[J].癌变.畸变.突变,2006,18(2):139-143. 被引量:4
  • 3伍亚舟,张彦琦,黄明辉,杨梦苏,曾志雄,易东.基因芯片表达数据的标准化策略研究[J].第三军医大学学报,2004,26(7):594-597. 被引量:17
  • 4Letteron P,Fromenty B,Terris B,et al.Acute and chronic hepatic steatosis lead to invivo lipid peroxidation in mice[J].Hepatology,1996,24(2):200-208. 被引量:1
  • 5Amacher DE,Martin BA.Tetracycline-induced steatosis in primary canine hepatocytecultures[J].Fundam Appl Toxicol,1997,40(2):256-263. 被引量:1
  • 6Miyazaki M,Dobrzyn A,Sampath H,et al.Reduced adiposity and liver steatosis bystearoyl-CoA desaturase deficiency are independent of peroxisome proliferator activatedreceptor-alpha[J].J Biol Chem,2004,279(33):35 017-35 024. 被引量:1
  • 7Watkins SM,Zhu X,Zeisel SH,et al.Phosphatidylethanolamine-N-methyltransferase activityand dietary choline regulate liver-plasma lipid flux and essential fatty acid metabolismin mice[J].Nature,2003,133(11):3 386-3 391. 被引量:1
  • 8Larsson SL,Skogsberg J,Bjorkegren J,et al.The low density lipoprotein receptor preventssecretion of dense apoB100-containing lipoproteins from the liver[J].J BiolChem,2004,279(2):831-836. 被引量:1
  • 9Letteron P,Sutton A,Mansouri A,et al.Inhibition of microsomal triglyceride transferprotein:another mechanism for drug-induced steatosis inmice.[J].Hepatology,2003,38(1):133-140. 被引量:1
  • 10Descalzi CF,Dozin B,Zerega B,et al.Extracellular fatty acid binding protein (ex-FABP)is a stress protein expressed during chondrocyte and myoblastdifferentiation[J].Osteoarthritis Cartilage,2001,9Suppl A:S118-122. 被引量:1

二级参考文献24

  • 1伍亚舟,张彦琦,黄明辉,杨梦苏,曾志雄,易东.基因芯片表达数据的标准化策略研究[J].第三军医大学学报,2004,26(7):594-597. 被引量:17
  • 2伍亚舟,易东,李辉智.基因表达芯片标准化研究进展[J].数理医药学杂志,2005,18(1):60-63. 被引量:3
  • 3敖琳,曾志雄,方志俊,胡冉,高利宏,杨梦苏,曹佳.小鼠毒理基因芯片的设计和制作[J].癌变.畸变.突变,2006,18(2):135-138. 被引量:8
  • 4Orphanides G.Toxicogenomics:challenges and opportunities[J].Toxicol Lett,2003(2),140-141.145-148m 被引量:1
  • 5Chuaqui RF,Bonner RF,Best CJM,et al.Post-analysis follow-up and validation of microarray experiments[J].Nat Genet,2002,32 (2):509-514. 被引量:1
  • 6Shioda T.Application of DNA microarray to toxicological research[J].J Environ Pathol Toxicol Oncol,2004,23(1):13-31. 被引量:1
  • 7Draghici S,Khatri P,Bhavsar P,et al.Onto-Tools,the toolkit of the modern biologist:Onto-Express,Onto-Compare,Onto-Design and Onto-Translate[J].Nucleic Acids Res,2003,31(13):3 775-3 781. 被引量:1
  • 8Simmons PT,Portier CJ.Toxicogenomics:the new frontier in risk analysis[J].Carcinogenesis,2002,23(6):903-905. 被引量:1
  • 9Stears RL,Martinsky T,Schena M.Trends in microarray analysis[J].Nat Med,2003,1(9):140-145. 被引量:1
  • 10Winzeler EA,Schena M,Davis RW.Fluorescence-based expression monitoring using microarrays[J].Methods Enzymol,1999,306(2):3-18. 被引量:1

共引文献22

同被引文献14

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部